Eiko Fried News Today

While much has been made about the power of these drugs to treat pernicious mental health issues, what gets lost are the people who get hurt in the process.

Psychedelic-assisted MDMA therapy for PTSD has shown some promise in the West, but plans to export it globally may be premature.

MDMA-assisted PTSD therapy has shown some promise in the West, but plans to export it globally are premature, critics say.

Excerpts from our first 100 episodes: a skeptical look at the Myers-Briggs test, what happens in the grieving brain, common myths of psychological science, and more.

The paradox of techno-optimism by embattled tech CEOs and prominent figures of psychiatry at a huge conference on the future of mental health.

There’s little evidence to prove how necessary or helpful many of the accepted norms in psychedelic-assisted therapy are—and some could even harm patients.

Warning of “history repeating,” researchers list ten problems with psychedelic research that make conclusions about efficacy and safety uncertain.

The causes of depression are much more complex than the serotonin hypothesis suggests

Despite new claims of "clear evidence" linking serotonin and depression, their study actually supports the opposite conclusion.

The psy-disciplines can't advance as a science built on diagnosis and biological reductionism—can system science provide a way forward?